These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22280408)

  • 1. Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand.
    van Turenhout ST; Terhaar sive Droste JS; Meijer GA; Masclée AA; Mulder CJ
    BMC Cancer; 2012 Jan; 12():46. PubMed ID: 22280408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dutch endoscopic capacity in the era of colorectal cancer screening.
    Terhaar sive Droste JS; Craanen ME; Kolkman JJ; Mulder CJ
    Neth J Med; 2006 Nov; 64(10):371-3. PubMed ID: 17122454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity.
    Joseph DA; Meester RG; Zauber AG; Manninen DL; Winges L; Dong FB; Peaker B; van Ballegooijen M
    Cancer; 2016 Aug; 122(16):2479-86. PubMed ID: 27200481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Dekker E; Nagtegaal ID; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I; van Leerdam ME
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1418-1425. PubMed ID: 32777553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.
    Comas M; Mendivil J; Andreu M; Hernández C; Castells X
    PLoS One; 2016; 11(10):e0164666. PubMed ID: 27732635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies.
    Hoffman RM; Stone SN; Herman C; Jung AM; Cotner J; Espey D; Kozoll R; Gavin MW
    Prev Chronic Dis; 2005 Jan; 2(1):A07. PubMed ID: 15670460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.
    Bronzwaer MES; Depla ACTM; van Lelyveld N; Spanier BWM; Oosterhout YH; van Leerdam ME; Spaander MCW; Dekker E;
    Gastrointest Endosc; 2019 Jan; 89(1):1-13. PubMed ID: 30240879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short Term Outcomes of Using Fecal Immunochemical Test for a Pilot Colorectal Cancer Screening Program. A Single Center Study on 3024 Consecutive Patients.
    Constantin A; Cazacu I; Ciocârlan M; Constantinescu C; Baltog G; Balahura C; Doraş I; Filip S; Filip G; Panazan I; Piţigoi D; Pirvu V; Turcu F; Copăescu C; Săftoiu A
    Chirurgia (Bucur); 2020; 115(4):448-457. PubMed ID: 32876018
    [No Abstract]   [Full Text] [Related]  

  • 14. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.
    Grobbee EJ; Kapidzic A; van Vuuren AJ; van Leerdam M; Lansdorp-Vogelaar I; Looman CW; Bruno MJ; Kuipers EJ; Spaander MC
    Am J Gastroenterol; 2015 Jul; 110(7):1072-7. PubMed ID: 26054624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test.
    Zorzi M; Senore C; Turrin A; Mantellini P; Visioli CB; Naldoni C; Sassoli De' Bianchi P; Fedato C; Anghinoni E; Zappa M; Hassan C;
    Gut; 2016 Nov; 65(11):1822-1828. PubMed ID: 26297727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade.
    Kooyker AI; Verbeek WH; van den Berg JG; Tesselaar ME; van Leerdam ME
    United European Gastroenterol J; 2020 Feb; 8(1):59-67. PubMed ID: 32213058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has National Colorectal Cancer Awareness Month increased endoscopy screening rates and public interest in colorectal cancer?
    Pantel HJ; Kleiman DA; Kuhnen AH; Marcello PW; Stafford C; Ricciardi R
    Surg Endosc; 2021 Jan; 35(1):398-405. PubMed ID: 32016518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous monitoring of colonoscopy performance in the Netherlands: first results of a nationwide registry.
    Nass KJ; van der Schaar PJ; van der Vlugt M; Ledeboer M; van Esch AAJ; van der Beek S; Lacle MM; van Leerdam ME; Ouwendijk RJT; Spaander MCW; Wouters MWJM; Fockens P; Dekker E
    Endoscopy; 2022 May; 54(5):488-495. PubMed ID: 34293811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of UK Colorectal Cancer Screening Pilot on hospital diagnostic services.
    Price J; Campbell C; Sells J; Weller D; Campbell H; Kenicer M; Dunlop M
    J Public Health (Oxf); 2005 Sep; 27(3):246-53. PubMed ID: 15870100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.